[197 Pages Report] The Women’s Health Market size was estimated at USD 43.23 billion in 2023 and expected to reach USD 46.99 billion in 2024, at a CAGR 8.97% to reach USD 78.90 billion by 2030.
The women’s health market includes diagnosis, treatments, medications, surgical procedures, and preventative measures for female-related disorders and diseases. The women’s health market focuses on improving disease management and enhancing the general health of the female population. The surging prevalence of hormonal disorders, osteoporosis, anemia, and breast cancer among women have raised the need for adequate diagnosis and appropriate treatment to improve women’s health globally. The growing awareness regarding self-healthcare and the availability of women’s health products, including multivitamins and protein supplements, is accelerating sales of women’s health products and supplements. However, the high cost associated with treating certain female diseases, including breast cancer, may prevent the female population from availing of the treatment. Additionally, the rising research and development (R&D) and the initiatives implemented by governments worldwide to raise awareness regarding early diagnosis of female diseases and to improve women’s health are expected to create significant potential to expand the use of women’s health products and may propel women to avail for medical treatments to treat the underlying medical conditions.
Regional Insights
The women’s health market in the Americas region is highly developed and is attributed to the rising number of female disorders and increasing awareness regarding self-healthcare among women in the region. The governments of the developed and emerging economies, including the U.S., U.K, Australia, Brazil, Canada, India, China, Japan, Germany, and France, among others, are taking initiatives to spread awareness regarding women’s diseases and to improve health o the female population across their respective nations. For instance, the Department of Health in Australia launched the National Women’s Health Strategy 2020 to 2030 to improve the health and well-being of all women in Australia, especially those at risk of poor health. Asian countries, including South Korea and Japan, are considerably producing various women’s health supplements that contain Vitamin E & C, Vitamin B12, marine collagen, protein, and other natural ingredients that can assist women in improving their overall health. Additionally, the rising approval of women’s health medications, including those for hormonal disorders and contraceptive pills, and the increasing commercialization of these products are expected to proliferate the use of women’s health products.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Women’s Health Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Women’s Health Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Women’s Health Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Agile Therapeutics, Inc., Alembic Pharmaceuticals Ltd., Amgen Inc., Apothecus Pharmaceutical Corp., Ar-Ex Laboratories Pvt. Ltd., AstraZeneca PLC, AVA Sciences by FemTec Health Inc., Bayer AG, Bharat Serums and Vaccines Ltd., Boston Imaging, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Ferring B.V., GE HealthCare, Gennev, Inc. by Unified Women’s Healthcare, Hologic, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mira by Quanovate Tech Inc., Mylan N.V. by Viatris, Novartis AG, Pfizer, Inc., Pregna International Ltd., Quest Diagnostics Incorporated, Serum Institute Of India Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Asia Pacific Pte Ltd., Teva Pharmaceutical Industries Ltd., The Himalaya Drug Company, TherapeuticsMD, Inc., Thermo Fisher Scientific Inc., Torrent Pharmaceuticals Ltd., and Triglobal Lifesciences (opc) Pvt. Ltd..
Market Segmentation & Coverage
This research report categorizes the Women’s Health Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Age
- 13-17 Years
- 18-35 Years
- 36 Years & Above
- Distribution Channel
- Hospital
- Online
- Retail
- Application
- Contraceptives
- Endometriosis & Uterine Fibroids
- Hormonal Infertility
- Menopause
- Polycystic Ovary Syndrome
- Postmenopausal Osteoporosis
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Women’s Health Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Women’s Health Market?
- What are the technology trends and regulatory frameworks in the Women’s Health Market?
- What is the market share of the leading vendors in the Women’s Health Market?
- Which modes and strategic moves are suitable for entering the Women’s Health Market?
US $
Euro €
GBP £